IAG933, a selective YAP1/TAZ-panTEAD PPI inhibitor

Time: 10:15 am
day: Conference Day One

Details:

  • The development and characterization of a direct pan-TEAD PPI inhibitor, IAG933
  • Preclinical data supporting efficacy with IAG933
  • Discovery of promising targeted therapy combinations with IAG933

Speakers: